Home / Stocks / NUS

Nu Skin Enterprises (NUS, Personal Care Products) Stock Valuation & Fair Value Fairly valued

Nu Skin Enterprises (NUS, Personal Care Products) trades at a blended P/E of 4.8, about 70% below its historical normal valuation, with a forward growth estimate of 17.0% and a PEG of 0.28. Analysts' one-year estimates have been hit 9% of the time. Priced at its historical normal P/E of 15.9 on the same blended earnings, the 2026-09-18 close of $4.58 corresponds to about $15.10 a share. This is a valuation reference, not a price target.

DATA AS OF 2026-09-21
Blended P/E
4.8
Normal P/E
15.9
PEG
0.28
Fwd growth
17.0%
Div yield
5.2%
RSI (14)
46.1
Neutral

Valuation flags

Verdict history

tickerseer's rating has been fairly valued since 2026-08-07.

Blended P/E and rating by weekBlended P/E moved from 4.7 to 4.8 between 2026-08-07 and 2026-09-21, against a normal P/E of 15.9, with 0 rating changes over 16 recorded weeks.2026-08-07: P/E 4.7, Fairly valued (recalculated)2026-08-10: P/E 5.0, Fairly valued2026-08-14: P/E 5.0, Fairly valued (recalculated)2026-08-17: P/E 4.8, Fairly valued2026-08-21: P/E 4.8, Fairly valued (recalculated)2026-08-24: P/E 4.8, Fairly valued2026-08-27: P/E 4.8, Fairly valued (recalculated)2026-08-28: P/E 4.8, Fairly valued (recalculated)2026-08-30: P/E 4.8, Fairly valued (recalculated)2026-08-31: P/E 5.0, Fairly valued2026-09-05: P/E 5.0, Fairly valued (recalculated)2026-09-07: P/E 5.0, Fairly valued2026-09-12: P/E 5.0, Fairly valued (recalculated)2026-09-14: P/E 5.1, Fairly valued2026-09-19: P/E 5.1, Fairly valued (recalculated)2026-09-21: P/E 4.8, Fairly valued5.010.015.0Aug 7Aug 18Aug 29Sep 10Sep 21Normal P/E 15.9
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

Selected weeks: the first, the latest, and the cheapest and dearest.

WeekBlended P/EPremium to normal P/ERating
2026-08-07P/E 4.7-71%Fairly valued
2026-09-14P/E 5.1-68%Fairly valued
2026-09-21P/E 4.8-70%Fairly valued ← now

Frequently asked questions

Is Nu Skin Enterprises stock overvalued?

At a blended P/E of 4.8 versus its historical normal P/E of 15.9, Nu Skin Enterprises trades about 70% below its typical valuation, with a PEG of 0.28 on 17.0% forward growth. tickerseer currently rates it fairly valued.

What is Nu Skin Enterprises's fair value and PEG?

Nu Skin Enterprises trades at a blended P/E of 4.8 against a historical normal P/E of 15.9, a PEG of 0.28, and a forward growth estimate of 17.0%. Priced at its historical normal P/E of 15.9 on the same blended earnings, the 2026-09-18 close of $4.58 corresponds to about $15.10 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Nu Skin Enterprises changed?

tickerseer's rating has been fairly valued since 2026-08-07.

Industry: Personal Care Products. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track NUS free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.